| Industry | 教育 | ||||||||||||||||||||||||
| Company Introduction | 中国高科集团股份有限公司是由全国174所高等院校及单位投资入股组建的新型高科技企业.从事生物医药、电子、通讯等高新技术领域的实业投资、创业投资及国内外贸易.十多年来,公司依托高校股东雄厚的科研技术力量,在科研开发、技术成果产业化及对外贸易方面取得长足发展.旗下子公司研发的"外用重组溶葡萄球菌酶"获得国家生物一类创新药物临床批文,该产品也是我国第一个拥有独立知识产权的抗感染生物一类新药。 | ||||||||||||||||||||||||
| Main Business | 教育及物业租赁业务 | ||||||||||||||||||||||||
| Legal Representative | 聂志强 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 任志强 | ||||||||||||||||||||||||
| Solicitors | 上海市第四律师事务所 | ||||||||||||||||||||||||
| Auditors | 大华会计师事务所 | ||||||||||||||||||||||||
| Tel No | 010-82524758;010-82524234 | ||||||||||||||||||||||||
| Fax No | 010-82524580 | ||||||||||||||||||||||||
| Website | www.chinahitech.com.cn | ||||||||||||||||||||||||
| hi-tech@china-hi-tech.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 26/07/1996 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.005 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 3.004 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 2.552B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |